Kuk-Hyun Kyung
Direktor/Vorstandsmitglied bei Aprinoia Therapeutics, Inc. /US/
Ursprung des Netzwerks ersten Grades von Kuk-Hyun Kyung
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA.
9
| Private Company | Biotechnology | 9 |
| Public Company | Packaged Software | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kuk-Hyun Kyung
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Thomas Jefferson University | College/University | Corporate Officer/Principal | |
| SK TELECOM CO., LTD. | Wireless Telecommunications | Director/Board Member | |
| MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Janssen R&D Ireland Ltd. | President | ||
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal | |
Nutter McClennen & Fish LLP
 Nutter McClennen & Fish LLP Miscellaneous Commercial ServicesCommercial Services Nutter McClennen & Fish LLP provides legal services. The firm serves to banking and financial services, energy, food and beverage, government entities, health care, information and technology, life science and manufacturing industries. The company was founded by Louis D. Brandeis and Samuel D. Warren in 1879 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| Brandeis University | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| New York University | College/University | Masters Business Admin Masters Business Admin | |
| Roosevelt University | College/University | Masters Business Admin | |
| University of Florida | College/University | Undergraduate Degree | |
| Seoul National University | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal | |
| Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
Institute of Human Virology
 Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Other Consumer Services | Chairman | |
| CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer | |
| Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
Recipharm (Americas), Inc.
 Recipharm (Americas), Inc. Pharmaceuticals: MajorHealth Technology Recipharm (Americas), Inc. manufactures pharmaceutical products. The firm specializes in contract dosage form development, pharmaceutical manufacturing, analytical services, biopharmaceutical development and manufacturing services. The company is headquartered in Morrisville, NC. | Pharmaceuticals: Major | General Counsel | |
Amerigen Pharmaceuticals Ltd.
 Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SERES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
| Northeastern University School of Law | College/University | Graduate Degree | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
| MUSTANG BIO, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
| CONVATEC GROUP PLC | Medical Specialties | Corporate Officer/Principal | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chairman | |
Brammer Bio LLC
 Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | General Counsel | |
| Janssen Therapeutics, Inc. | President | ||
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Biotechnology | Chief Executive Officer | |
| Pomerantz Life Sciences Consulting Group LLC | President | ||
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Arranta Bio Holdings LLC
 Arranta Bio Holdings LLC BiotechnologyHealth Technology Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA. | Biotechnology | General Counsel | |
On Demand Pharmaceuticals, Inc.
 On Demand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology On Demand Pharmaceuticals, Inc. is an innovative technology company that is transforming the way medicines are made. On Demand Pharmaceuticals is based in Richmond, VA and was founded by Shiu Fei Ling. The private company's breakthrough manufacturing technology platform, the Pharmacy on Demand (POD), allows for the production of medicines on demand, wherever and whenever they are needed. The company's mission is to provide an adequate, safe, and reliable supply of medicines to every community worldwide. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Troutman Pepper LLP | Corporate Officer/Principal | ||
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 41 |
| Israel | 4 |
| Südkorea | 3 |
| Irland | 3 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 3 |
| Communications | 2 |
Operativ
| Director/Board Member | 85 |
| Corporate Officer/Principal | 29 |
| Chairman | 23 |
| Chief Executive Officer | 17 |
| Independent Dir/Board Member | 12 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nitin Hariyantlal Datanwala | 32 |
| Roger Pomerantz | 30 |
| In-Joon Hwang | 29 |
| Xin Hui | 14 |
| Jae-Seung Yoon | 11 |
| Lana Gladstein | 11 |
| Mark Shearman | 10 |
| Brian Achenbach | 8 |
| Zhi Gang Luo | 8 |
| Ming-Kuei Jang | 6 |
| Sanghun Kim | 6 |
| Chang-Hyeon Song | 5 |
| Yeong-Chan Yoon | 3 |
| Gyu-Chan Jo | 2 |
| Min Kim | 2 |
- Börse
- Insiders
- Kuk-Hyun Kyung
- Unternehmensverbindungen